Mental Health

A California clinic known for ketamine bets on the booming NAD+ IV market. As wellness clinics expand, experts question if the science supports the high price tag.

As Québec's population ages, a major healthcare union launches a campaign to confront systemic failures in senior care, challenging government strategy.

A Las Vegas clinic offers a specialized program for first responders battling trauma and addiction. But does it address the systemic crisis facing our heroes?

An ancient herb's revival is more than a wellness trend. It’s a forensic look at a market grappling with sustainability, cultural respect, and a search for authentic calm.

How a sparkling water brand and a grocery chain are humanizing corporate giving by empowering communities to support veterans, one service dog at a time.

For decades, insomnia treatment meant risky sedatives. Now, a new class of drugs is revolutionizing sleep science, promising safer rest for millions.

Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British Columbia's status as a global hub for health innovation.

A new study of 100M insurance claims reveals a shocking failure: nearly 9 in 10 women in some states get no osteoporosis care after a fracture. Why?

For years, CIDP patients faced limited options. Now, a wave of targeted therapies promises to transform treatment, sparking a multi-billion dollar market boom.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

A Taipei delegation at BIO 2026 signals Taiwan's strategic pivot from manufacturing to R&D, seeking global partners for its late-stage drugs and platforms.

At BIO 2026, Transpire Bio isn't just presenting; it's pitching a new paradigm for medicine, using inhalation to tackle everything from diabetes to cancer.

A massive new study reveals leaders are wrong to go silent on climate. The data shows talking about pollution, health, and household costs wins broad support.

GSK and Spero Therapeutics have won FDA approval for Utebzi, the first oral carbapenem for complex UTIs, a move that could slash healthcare costs.

Salinas Valley Health’s student art initiative is more than a feel-good story; it’s a strategic blueprint for how organizations can build lasting competitive advantage by investing in local identity.

A major healthcare provider is investing in home repairs in Flint, MI. It's more than charity; it's a strategic move to tackle health crises at their source.

Phoenix Pathways isn't just a building; it's a new model for tackling chronic homelessness by integrating housing, healthcare, and human support under one roof.

Beyond the headlines of government appointments, Canada is placing a strategic bet on specialized expertise to redesign its social and economic future for an aging nation.

As overdose deaths skyrocket among Black and Indigenous communities, a new webinar confronts the systemic failures and charts a course for equitable care.